Furthermore, APP−/− mESC-TEP-treated mice performed better than APP+/+ mESC-TEP-treated mice, almost reaching the performance level observed in wild-type (WT) non-AD mice (Figure 2A). The gene discussed is APP; the disease is Alzheimer disease.